Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
335,607
-
Share change
-
+157,378
-
Total reported value
-
$788,000
-
Price per share
-
$2.35
-
Number of holders
-
12
-
Value change
-
+$369,454
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q4 2021
As of 31 Dec 2021,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
335,607 shares.
The largest 10 holders included
STATE STREET CORP, ENVESTNET ASSET MANAGEMENT INC, TWO SIGMA SECURITIES, LLC, TRUE Private Wealth Advisors, MORGAN STANLEY, ExodusPoint Capital Management, LP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, CREDIT AGRICOLE S A, and ROYAL BANK OF CANADA.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.